ICMR plans pan-India seroprevalence studiesJuly 11, 2020 0 By FM
The Indian Council of Medical Research (ICMR) plans to launch a second new pan India serological survey to help assess the extent of the spread of COVID-19 infection in the country.
The seroprevalence survey is conducted to detect the Immunoglobulin G (IgG) antibodies in the blood serum of the individuals. The antibodies actually start appearing after two weeks of the onset of the viral infection. These antibodies may last for several months even after a COVID-19 patient has recovered, and thus the detection of its presence enables for estimation of the incidence of the infection.
Findings of such surveys will not only help the government and ICMR assess the extent of the spread of COVID-19 in India or in specific areas, but also evaluate the evolving trend of the infection which may be crucial in research as well as framing future policy interventions.
ICMR announced that the apex body is working towards increasing the outreach of testing and make COVID-19 testing available at a district level.
Prior to the upcoming survey one such survey was conducted in April across 21 states of which the final results are yet to be published.
These studies are subject to peer-review, and currently, ICMR’s pilot survey that was done around mid-April is being peer-reviewed and that process is going on. according to health ministry officials.